psychedelics
Marvel Biosciences starts work on psychedelics-inspired compounds
The Calgary-based life sciences company hopes to develop treatments for mental health conditions.
Love Pharma to develop psilocybin-infused oral strips
Sublingual or the administration of medicines under the tongue allows for quick absorption.
Cybin Inc. seeks patent for inhalation delivery of psychedelic medications
The Toronto company is developing a psychedelic drug for anxiety disorders.
Academic reflects on bioethical issues in medicalization of psychedelics
Australian researcher cites need to explore ethical issues regarding the use of psychedelics as medicine.
Nova Mentis looks at potential psilocybin treatment for obesity and diabetes
People with obesity and diabetes may have an alternative way to get better with the psychedelic substance psilocybin.
Awakn Life Sciences starts study on ketamine treatment for gambling addiction
Toronto-based biotechnology company Awakn has a research program on ketamine-assisted psychotherapy against multiple addictions.
Vancouver’s Havn Life announces first psilocybin mushroom harvest in Jamaica
Vancouver biotechnology company Havn Life will export yield to UBC-based Delic Labs for quality control and testing.
Psychedelics researcher explains why a bad trip is a good one after all
Petter Grahl Johnstad of the University of Bergen says a bad psychedelics trip can be a way to confront personal demons.
Psychedelics linked to better mental health amid COVID-19 pandemic
A study in Argentina finds association between the use of psychedelic substances with positive mental health outcomes.